YU64192A - Analozi insulina - Google Patents
Analozi insulinaInfo
- Publication number
- YU64192A YU64192A YU64192A YU64192A YU64192A YU 64192 A YU64192 A YU 64192A YU 64192 A YU64192 A YU 64192A YU 64192 A YU64192 A YU 64192A YU 64192 A YU64192 A YU 64192A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- insulin analogs
- insulin
- sequence
- human insulin
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Opisani su analozi insulina i postupak za njihovo dobijanje kao i formulacije koje sadrže analoge insulina zajedno sa farmaceutski prihvatljivim ekscipijentima, razblaživačima i nosačima, pri čemu postupak obuhvata modifikovanje analoga humanog insulina sa odredjenim izmenama aminokiselina na odred-jenim mestima u B-nizu i A-nizu nativnog humanog insulina i uklanjanje tripeptida ili tetrapeptida sa karboksilnog kraja B-niza nativnog humanog insulina. Analozi insulina prema ovom pronalasku u obliku formulacija koje sadrže pomenute analoge insulina se upotrebljavaju za lečenje hiperglikemije i pokazuju značajne prednosti u odnosu na humani insulin.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71857491A | 1991-06-21 | 1991-06-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU64192A true YU64192A (sh) | 1994-06-10 |
Family
ID=24886590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU64192A YU64192A (sh) | 1991-06-21 | 1992-06-19 | Analozi insulina |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0519750A3 (sh) |
JP (1) | JPH05271283A (sh) |
CN (1) | CN1069737A (sh) |
AU (1) | AU1837792A (sh) |
BR (1) | BR9202322A (sh) |
CA (1) | CA2071382A1 (sh) |
CZ (1) | CZ186492A3 (sh) |
FI (1) | FI922882A (sh) |
HU (1) | HUT61581A (sh) |
IE (1) | IE921997A1 (sh) |
IL (1) | IL102240A0 (sh) |
MX (1) | MX9202987A (sh) |
NO (1) | NO922376L (sh) |
NZ (1) | NZ243229A (sh) |
TW (1) | TW222643B (sh) |
YU (1) | YU64192A (sh) |
ZA (1) | ZA924448B (sh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994014461A1 (en) * | 1992-12-18 | 1994-07-07 | Eli Lilly And Company | Insulin analogs |
US20020111461A1 (en) | 1999-05-21 | 2002-08-15 | Todd C. Somers | Low molecular weight peptidomimetic growth hormone secretagogues |
ES2266187T3 (es) | 2000-03-24 | 2007-03-01 | Genentech, Inc. | Uso de la insulina para el tratamiento de trastornos del cartilago. |
EP1862174A1 (en) * | 2005-03-02 | 2007-12-05 | Ajinomoto Co., Inc. | Inhibitor for insulin polymer formation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH25772A (en) * | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
AU612141B2 (en) * | 1987-02-25 | 1991-07-04 | Novo Nordisk A/S | Novel insulin derivatives |
US4992418A (en) * | 1987-07-17 | 1991-02-12 | Mount Sinai School Of Medicine | Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin |
PT93057B (pt) * | 1989-02-09 | 1995-12-29 | Lilly Co Eli | Processo para a preparacao de analogos da insulina |
-
1992
- 1992-06-17 CZ CS921864A patent/CZ186492A3/cs unknown
- 1992-06-17 TW TW081104742A patent/TW222643B/zh active
- 1992-06-17 ZA ZA924448A patent/ZA924448B/xx unknown
- 1992-06-17 NO NO92922376A patent/NO922376L/no unknown
- 1992-06-17 IL IL102240A patent/IL102240A0/xx unknown
- 1992-06-17 CA CA002071382A patent/CA2071382A1/en not_active Abandoned
- 1992-06-18 AU AU18377/92A patent/AU1837792A/en not_active Abandoned
- 1992-06-18 HU HU9202048A patent/HUT61581A/hu unknown
- 1992-06-18 MX MX9202987A patent/MX9202987A/es unknown
- 1992-06-18 FI FI922882A patent/FI922882A/fi unknown
- 1992-06-19 YU YU64192A patent/YU64192A/sh unknown
- 1992-06-19 CN CN92105888A patent/CN1069737A/zh active Pending
- 1992-06-19 NZ NZ243229A patent/NZ243229A/en unknown
- 1992-06-19 EP EP19920305678 patent/EP0519750A3/en not_active Withdrawn
- 1992-06-19 BR BR929202322A patent/BR9202322A/pt not_active Application Discontinuation
- 1992-06-19 JP JP4160813A patent/JPH05271283A/ja not_active Withdrawn
- 1992-07-01 IE IE199792A patent/IE921997A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IE921997A1 (en) | 1992-12-30 |
ZA924448B (en) | 1993-12-17 |
BR9202322A (pt) | 1993-01-19 |
EP0519750A2 (en) | 1992-12-23 |
NO922376D0 (no) | 1992-06-17 |
CA2071382A1 (en) | 1992-12-22 |
JPH05271283A (ja) | 1993-10-19 |
IL102240A0 (en) | 1993-01-14 |
FI922882A0 (fi) | 1992-06-18 |
MX9202987A (es) | 1993-01-01 |
AU1837792A (en) | 1992-12-24 |
TW222643B (sh) | 1994-04-21 |
NZ243229A (en) | 1994-09-27 |
CZ186492A3 (en) | 1993-01-13 |
FI922882A (fi) | 1992-12-22 |
EP0519750A3 (en) | 1993-06-23 |
HUT61581A (en) | 1993-01-28 |
HU9202048D0 (en) | 1992-09-28 |
NO922376L (no) | 1992-12-22 |
CN1069737A (zh) | 1993-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0100928A2 (hu) | Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
ES8704973A1 (es) | Un procedimiento para la preparacion de un peptido. | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
ES2178000T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
DE68928810T2 (de) | Analoge vom menschlichen Insulin | |
ES2063350T3 (es) | Nuevas proteinas con efecto inhibidor del tnf y su produccion. | |
MX9703643A (es) | Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana. | |
IL72018A (en) | Biologically active heptapeptides structurally related to region within growth hormones and pharmaceutical compositions comprising them | |
ES2054353T3 (es) | Expresion de las alipoproteinas humanas ai-milano en levadura. | |
HU9200548D0 (en) | Improved activity process of recombined proteins | |
DK0482013T3 (da) | Ikke-glycolyserede humant interleukin-3 analoge proteiner | |
MX9703642A (es) | Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana. | |
NO932148L (no) | Fusjonspolypeptider | |
CA1188218A (en) | PURIFIED ANTINEOPLASTIC FRACTIONS AND METHODS OF TREATMENT OF NEOPLASMS | |
KR900701832A (ko) | 항-트롬빈 | |
DE3261304D1 (en) | Retro-inverso analogues of c-terminal penta and hexapeptides of substance p. | |
DK482185A (da) | Peptider, deres fremstilling og anvendelse som laegemidler | |
YU64192A (sh) | Analozi insulina | |
ES2114555T3 (es) | Nuevo interferon gamma humano recombinado. | |
FI93843C (fi) | Menetelmä angiogeenisen tekijän tuottamiseksi | |
ES2071038T3 (es) | Peptidos asociados al hiv. | |
DE59409413D1 (de) | Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
PT87239A (pt) | Process for the preparation of peptides | |
SE8703855D0 (sv) | Vasoaktiva peptider | |
JPS5767591A (en) | Protein element substance and its preparation |